NEW YORK ─ Oxford Immunotec on Thursday announced that it has obtained CE marking for its T-Spot.COVID test, which provides qualitative detection of the T-cell mediated immune response to SARS-CoV-2 in whole blood.
It has also applied for Emergency Use Authorization from the US Food and Drug Administration for the test.